These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Our first experiences with the new hypotensive drug Catapresan]. Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771 [No Abstract] [Full Text] [Related]
45. Therapeutic implications of recent megatrials in hypertension: in favor of new drugs. Volpe M; Tocci G J Nephrol; 2007; 20 Suppl 12():S12-8. PubMed ID: 18050137 [TBL] [Abstract][Full Text] [Related]
46. [Clinical studies with the new antihypertensive agent Catapresan]. Jüngling K Med Welt; 1968 Sep; 39():2105-13. PubMed ID: 4887319 [No Abstract] [Full Text] [Related]
47. [A clinical trial of guanoxabenz: a hypotensive agent with central and hypertensive action (author's transl)]. Ledoux F; Welsch M; Steimer C; Schwartz J Therapie; 1981; 36(2):187-91. PubMed ID: 7027519 [No Abstract] [Full Text] [Related]
48. Comparative efficacy and safety of lofexidine and clonidine given alone or concomitantly with hydrochlorothiazide in hypertensive outpatients. Beitman RE; Kuzma RJ; McMahon FG; Morledge J; Mroczek W; Rolf CN; Tsai TH Arzneimittelforschung; 1982; 32(8a):988-93. PubMed ID: 6753858 [No Abstract] [Full Text] [Related]
49. [Goal blood pressure values from the nephrologic viewpoint]. Hörl WH Wien Med Wochenschr; 1999; 149(23-24):629-32. PubMed ID: 10721158 [TBL] [Abstract][Full Text] [Related]
50. The Australian National Blood Pressure Study: a therapeutic trial in mild hypertension. Aust Fam Physician; 1981 Apr; 10(4):234, 237-9. PubMed ID: 7018480 [No Abstract] [Full Text] [Related]
51. [Diagnosis of hypertension in general practice. Unnecessary procedures]. Aumiller J MMW Fortschr Med; 2006 Jan; 148(3):6, 8. PubMed ID: 16475616 [No Abstract] [Full Text] [Related]
52. Clinical trials with CIBA 1507--Go, a new antihypertensive compound. Misra RC; Gupta SK; Chuttani HK J Assoc Physicians India; 1970 Dec; 18(12):979-82. PubMed ID: 5509035 [No Abstract] [Full Text] [Related]
53. The Australian National Blood Pressure Study. Doyle AE Aust Fam Physician; 1981 Jul; 10(7):558-9. PubMed ID: 7025820 [No Abstract] [Full Text] [Related]
54. Clinical evaluation of the antihypertensive effects of debrisoquin, a new postganglionic vasodepressor agent. Talbot FJ Med Ann Dist Columbia; 1965 Dec; 34(12):580-3. PubMed ID: 5321849 [No Abstract] [Full Text] [Related]
55. [Clinical and hemodynamic study of a new antihypertensive agent]. Palmero HA; Caeiro AE; Lussi H; Massari P; Amuchastegui S Prensa Med Argent; 1968 Aug; 55(25):1212-6. PubMed ID: 4885121 [No Abstract] [Full Text] [Related]
56. [Treatment of arterial hypertension: clinical observations on a new pharmacologic association]. Migheli B; Campus S; Accatino G; Dessy P; Anselmino A Minerva Med; 1965 Sep; 56(75):3211-3. PubMed ID: 5319789 [No Abstract] [Full Text] [Related]
58. ESH-ESC guidelines for the management of hypertension. Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473 [TBL] [Abstract][Full Text] [Related]
59. How fast and how low blood pressure to be lowered in hypertensives? Arya SN; Ranjan P J Indian Med Assoc; 1997 Aug; 95(8):451-3. PubMed ID: 9492452 [No Abstract] [Full Text] [Related]
60. Clinical evaluation of debrisoquin in the treatment of hypertension. Rosendorff C; Marsden CD; Cranston WI Arch Intern Med; 1968 Dec; 122(6):487-90. PubMed ID: 5721874 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]